Mov Disord Vol 33, Suppl 2 Archives - Page 13 of 177 - MDS Abstracts

2018 International Congress
Symptomatic Isolated Tongue Tremor of Cortical Origin Due to Stroke
S. Thakolwiboon, D. Ruthirago, P. Laengvejkal, J. Kim, H. Wilms (Lubbock, TX, USA)
Objective: To present an unusual case of transient, isolated tongue tremor from an ischemic stroke. Background: Isolated tongue tremor is an uncommon neurological symptom. A…
2018 International Congress
A functional micro-electrode mapping of ventral thalamus in Essential Tremor
D. Pedrosa, P. Brown, H. Cagnan, V. Visser-Vandewalle, J. Wirths, L. Timmermann, J. Stuart-Brittain (Marburg, Germany)
Objective: Understanding the pathomechanisms of Essential Tremor (ET) with higher spatial and temporal precision is of important clinical relevance. While the efficiency of Deep Brain…
2018 International Congress
Botulinum toxin injections improve daily life activities in patients with upper limb tremor
A. Kreisler, B. Bouchain, L. Defebvre (Lille, France)
Objective: To describe a group of patients with an upper limb tremor refractory to per os medications and receiving Botulinum NeuroToxin type A (BoNT-A) injections.…
2018 International Congress
Neurocognitive outcomes of STN-DBS in patients with Parkinson’s disease: A 10-year review of local experiences in Hong Kong
V. Tang, X.L. Zhu, D. Chan, C. Lau, A. Chan, V. Mok, J. Yeung, W.S. Poon (Hong Kong)
Objective: The purpose of the study was to determine the long-term neurocognitive outcomes of STN-DBS for PD. Background: Cognitive disturbances is one of the most…
2018 International Congress
Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative
K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)
Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
2018 International Congress
Opposite effects of dopamine on specific NoGo perfomance in young and late onset Parkinson’s disease and the relationship to nigrostriatal degeneration
D. Kübler, H. Schroll, U. Scheller, R. Buchert, A. Kühn (Berlin, Germany)
Objective: To investigate inhibitory control under dopamine (DA) in Parkinson’s disease (PD). Background: The pattern of degeneration in PD as well as side effects of…
2018 International Congress
Turning during gait is associated with gray matter density of the nucleus basalis of Meynert in Parkinson’s disease
R. Morris, T. Madhyastha, D. Martini, K. Smulders, J. Quinn, V. Kelly, K. Edwards, C. Zabetian, T. Grabowski, F. Horak (Portland, OR, USA)
Objective: To examine whether turning during gait is associated with gray matter (GM) density of the nucleus basalis of Meynert (nbM) and attention in people…
2018 International Congress
Early synaptic loss and synaptic instability in a mouse model of prodromal Parkinson’s disease
Y. Hatanaka, R. Takahashi (Kyoto, Japan)
Objective: In order to elucidate very early pathologis of Parkinson’s disease (PD), we focused on synaptic pathologies in a newly developed mouse model of prodromal…
2018 International Congress
Knockdown of eEF1A2 reduced neuronal survival in a SH-SY5Y cellular model of Parkinson’s disease through the PI3K/Akt/mTOR pathway
K. Khwanraj, P. Dharmasaroja (Bangkok, Thailand)
Objective: To investigate whether eEF1A2 promotes neuronal survival through PI3K/Akt/mTOR pathway in a toxin-induced Parkinson’s disease model. Background: Parkinson’s disease is a common neurodegenerative disorder…
2018 International Congress
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) -mediated ubiquitination attributed to localization of Mortalin to mitochondria
L. Wu, W. Yang, Y. Tan, J. Ding, S. Chen (Shanghai, China)
Objective: The pathogenic mechanism of UCHL1 in PD remains unclear. In this study, we aimed to investigate the role of UCHL1 in the pathogenesis of…